Johnson & Johnson antidepressant spray approved for treating those at risk of suicide

Spravato has been approved as the first antidepressant for actively suicidal patients as doctors are becoming increasingly concerned about COVID-19’s effect on mental health.
Read More

Leave a Reply

%d bloggers like this: